Celltrion
068270.KS
#772
Rank
C$35.87 B
Marketcap
$173.19
Share price
1.34%
Change (1 day)
-3.85%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total assets

Total assets on the balance sheet as of June 2024 : C$20.36 Billion

According to Celltrion 's latest financial reports the company's total assets are C$20.36 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celltrion - Total assets on balance sheet (from 2007 to 2024)

Total assets by year

Year Total assets Change
2022-12-31C$6.34 B4.33%
2021-12-31C$6.07 B3.15%
2020-12-31C$5.89 B35.15%
2019-12-31C$4.35 B1.98%
2018-12-31C$4.27 B10.04%
2017-12-31C$3.88 B20.84%
2016-12-31C$3.21 B3.14%
2015-12-31C$3.11 B26.68%
2014-12-31C$2.46 B23.17%
2013-12-31C$1.99 B20.34%
2012-12-31C$1.65 B34.44%
2011-12-31C$1.23 B20.49%
2010-12-31C$1.02 B100.48%
2009-12-31C$0.51 B4.6%
2008-12-31C$0.48 B638.35%
2007-12-31C$66.18 M